Your session is about to expire
← Back to Search
Treatment for Frontotemporal Dementia
N/A
Waitlist Available
Led By Howie Rosen, MD
Research Sponsored by The Bluefield Project to Cure Frontotemporal Dementia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights
Summary
This is a biomarker study designed to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) mutations compared to a control group of individuals without known f-FTLD mutations. The NSP is an ancillary study to the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration" (ALLFTD) study, NCT04363684. More information can be found at https://www.allftd.org/.
Eligible Conditions
- Frontotemporal Dementia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Neurofilament Light Chain Levels
Secondary outcome measures
Intersubject variability of plasma NfL measurements
Logistics measure
Other outcome measures
Clinical and MRI correlates
Other biomarker evaluation
Find a Location
Who is running the clinical trial?
The Bluefield Project to Cure Frontotemporal DementiaLead Sponsor
2 Previous Clinical Trials
1,497 Total Patients Enrolled
1 Trials studying Frontotemporal Dementia
1,489 Patients Enrolled for Frontotemporal Dementia
Mayo ClinicOTHER
3,298 Previous Clinical Trials
3,958,110 Total Patients Enrolled
12 Trials studying Frontotemporal Dementia
11,915 Patients Enrolled for Frontotemporal Dementia
University of California, San FranciscoOTHER
2,551 Previous Clinical Trials
15,257,551 Total Patients Enrolled
15 Trials studying Frontotemporal Dementia
7,881 Patients Enrolled for Frontotemporal Dementia
Share this study with friends
Copy Link
Messenger